Current status of xenotransplantation

JAMA

Volumn 301, Issue 9, 2009, Pages 967-969

  Pierson III, Richard N ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MODIFICATION; GOVERNMENT; GRAFT REJECTION; HEALTH CARE COST; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MEDICAL ETHICS; NONHUMAN; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOTIC THROMBOCYTOPENIC PURPURA; XENOTRANSPLANTATION; ANIMAL; ARTICLE; CLINICAL TRIAL; ETHICS; MEDICAL RESEARCH; METHODOLOGY; ORGAN TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; RISK; STANDARD; XENOGRAFT;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; ORGAN TRANSPLANTATION; RESEARCH DESIGN; RISK; TRANSPLANTATION, HETEROLOGOUS;

EID: 61549131748     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.237     Document Type: Note

References (15)

1. Cooper DK, Dorling A, Pierson RN III,et al. Alpha 1,3- galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here? Transplantation. 2007;84(1):1-7.
2. Allan JS. The risk of using baboons as transplant donors: exogenous and endogenous viruses. Ann N Y Acad Sci. 1998;862:87-99.
3. DiabeCell. Life-changing cellular therapy for type 1 diabetes. http://www lctglobal.com/lct-diabecell-diabetes-treatment.php. Accessed January 29, 2009.
4. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3- galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med. 2005;11(1):32-34.
5. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med. 2005;11(1):29-31.
6. Shimizu A, Yamada K, Yamamoto S, et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol. 2005;16(9):2732-2745.
7. Schulte am Esch J II, Rogiers X, Robson SC. Molecular incompatibilities in he-mostasis between swine and men: impact on xenografting. Ann Transplant. 2001; 6(3):12-16.
8. Wu G, PfeifferS, Schroder C, et al. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes. Xenotransplantation. 2007;14(1):34-47.
9. Rees MA. Immunological Effects of Hepatic Xenoperfusion [PhD thesis]. Cambridge, England: University of Cambridge; 2003.
10. Naruse K, Tang W, Makuuch M. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients. World J Gastroenterol. 2007;13(10):1516-1521.
11. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med. 2006;12(3):301-303.
12. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006, 12(3)304-306.
13. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant. 2004;4(9):1383-1390.
14. The Transplantation Society. International Xenotransplantation Association. http://www. transplantation-soc.org/sections.php?s=01 .Accessed January 29,2009.
15. Pierson RN III, Winn HJ, Russell PS, Auchincloss H Jr. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med. 1989;170(3): 991-996.